Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

NCT02513355 is registered in ClinicalTrials.gov with Nanjing NingQi Medicine Science and Technology Co., Ltd. as lead sponsor.

NCT NCT02513355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02513355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research
Lead sponsor
Nanjing NingQi Medicine Science and Technology Co., Ltd.
Phase
Phase 4
Overall status
Unknown status
Start date
February 28, 2015
Completion date
Not reported
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer